Skip to main content

Advertisement

SpringerLink
Log in

Induced Hypertension or Intravenous Milrinone for Cerebral Vasospasm: Why Choose?

  • Response
  • Published:
Neurocritical Care Aims and scope Submit manuscript

The Original Article was published on 03 November 2021

The Original Article was published on 03 September 2021

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lakhal K, Hivert A, Alexandre P-L, Fresco M, Robert-Edan V, Rodie-Talbere P-A, et al. Intravenous milrinone for cerebral vasospasm in subarachnoid hemorrhage: the MILRISPASM controlled before-after study. Neurocrit Care. 2021. https://doi.org/10.1007/s12028-021-01331-z.

    Article  PubMed  Google Scholar 

  2. Abulhasan YB, Ortiz Jimenez J, Teitelbaum J, Angle MR. Role of induced hypertension and intravenous milrinone after aneurysmal subarachnoid hemorrhage: is it time to shift the paradigm? Neurocrit Care Press.

  3. Diringer MN, Bleck TP, Claude Hemphill J, Menon D, Shutter L, Vespa P, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15:211–40.

    Article  Google Scholar 

  4. Velly LJ, Bilotta F, Fabregas N, Soehle M, Bruder NJ, Nathanson MH. Anaesthetic and ICU management of aneurysmal subarachnoid haemorrhage: a survey of European practice. Eur J Anaesthesiol. 2015;32:168–76.

    CAS  PubMed  Google Scholar 

  5. Gathier CS, van den Bergh WM, van der Jagt M, Verweij BH, Dankbaar JW, Müller MC, et al. Induced hypertension for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a randomized clinical trial. Stroke. 2018;49:76–83.

    Article  Google Scholar 

Download references

Funding

No funding was required for this study.

Author information

Authors and Affiliations

  1. Service d’Anesthésie-Réanimation, Hôpital Laënnec, Centre Hospitalier Universitaire, 44093, Nantes, France

    Karim Lakhal, Antoine Hivert, Bertrand Rozec & Julien Cadiet

  2. Centre National de la Recherche Scientifique, Institut du Thorax, Institut National de la Santé et de la Recherche Médicale, National de la Recherche Scientifique, Université de Nantes, Nantes, France

    Bertrand Rozec

Authors
  1. Karim Lakhal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antoine Hivert
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bertrand Rozec
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Julien Cadiet
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Authorship requirements have been met, and the final manuscript was approved by all authors.

Corresponding author

Correspondence to Karim Lakhal.

Ethics declarations

Conflicts of interest

Karim Lakhal has no conflicts of interest in connection with the work submitted. In addition, during the past 3 years, KL received congress registration fees from Sanofi-Aventis (once in 2018), travel fees from MSD France (once in 2017), Gilead Sciences (once in 2017), Pfizer (three times: in 2019, 2020, and 2021), and Correvio Pharma (twice in 2020, once in 2021). Bertrand Rozec has no conflicts of interest in connection with the work submitted. In addition, during the past 5 years, BR received lecture fees from Fisher & Paykel, Baxter International, LFB, Aspen, research grants from Baxter, and consulting fees from LFB and AstraZeneca. None of the other authors have any financial or nonfinancial competing interest in connection with this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lakhal, K., Hivert, A., Rozec, B. et al. Induced Hypertension or Intravenous Milrinone for Cerebral Vasospasm: Why Choose?. Neurocrit Care 35, 922–923 (2021). https://doi.org/10.1007/s12028-021-01378-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-021-01378-y

Search

Navigation